Kallistatin protects against bleomycin-induced idiopathic pulmonary fibrosis by inhibiting angiogenesis and inflammation

Aberrant angiogenesis and vascular remodeling are the main features of idiopathic pulmonary fibrosis. Kallistatin is an anti-angiogenic peptide with known effects on endothelial cells. This study aimed to demonstrate that kallistatin has beneficial effects on bleomycin (BLM)-induced pulmonary fibros...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Transl Res
Autors principals: Huang, Xiaoping, Wang, Xiao, Xie, Xiaolan, Zeng, Shulan, Li, Zhaofa, Xu, Xianxiang, Yang, Huiyong, Qiu, Fei, Lin, Junsheng, Diao, Yong
Format: Artigo
Idioma:Inglês
Publicat: e-Century Publishing Corporation 2017
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5375993/
https://ncbi.nlm.nih.gov/pubmed/28386328
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars